Risk factor
Very poor trading liquidity
Profitability factor
Solid dividends
About
Founded in 1954, Ilsung Pharmaceuticals Co., Ltd. operates as a key pharmaceutical firm in South Korea, headquartered in Seoul. The company specializes in the development and distribution of a comprehensive range of medicinal products. Its extensive portfolio includes antibacterial agents, pain management drugs, muscle relaxants, anticoagulants, various cardiovascular and circulatory system treatments, diagnostic contrast agents, diabetes therapies, gastrointestinal medicines, antiviral compounds, anti-emetic medications, respiratory care solutions, anesthetics, and antipyretics.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is trading at neutral levels on P/FCF.